Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.995
-0.155 (-3.73%)
May 29, 2026, 4:00 PM EDT - Market closed
Apyx Medical Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Apyx Medical stock has a consensus rating of "Strong Buy" and an average price target of $6.50. The average 1-year stock price forecast is 62.70% higher than the current stock price, while the lowest is $6.00 (+50.19%) and the highest is $8.00 (+100.25%).
Price Target: $6.50 (+62.70%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Apyx Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Reiterates $6 | Buy | Reiterates | $6 | +50.19% | May 8, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $6 | Buy | Reiterates | $6 | +50.19% | Apr 14, 2026 |
| BTIG | BTIG | Buy Upgrades $6 | Buy | Upgrades | $6 | +50.19% | Mar 11, 2026 |
Financial Forecast
Revenue This Year
60.76M
from 52.84M
Increased by 14.97%
Revenue Next Year
67.07M
from 60.76M
Increased by 10.40%
EPS This Year
-0.29
from -0.27
EPS Next Year
-0.27
from -0.29
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 62.9M | 71.4M | |||
| Avg | 60.8M | 67.1M | |||
| Low | 58.2M | 61.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 19.1% | 17.5% | |||
| Avg | 15.0% | 10.4% | |||
| Low | 10.0% | 1.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.26 | -0.21 | |
| Avg | -0.29 | -0.27 | |
| Low | -0.30 | -0.30 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.